Company research / WHWK
Whitehawk Therapeutics, Inc. (WHWK)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Whitehawk Therapeutics, Inc. reported revenue of $7.14M. Revenue fell 72.5% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $0.
Key ratios (year ended 2025-12-31)
89.4%
Gross margin (computed)
n/m
Operating margin
-288.3%
Net margin
-15.1%
Return on year-end equity
-72.5%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.